Sources | Names Used |
---|---|
CCLE, CTRPv2 | L-685458 |
PharmacoGx | L-685458 |
Database | Identifier |
---|---|
Smiles: | CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(=O)N)NC(=O)C(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OC(C)(C)C)O |
Inchikey: | MURCDOXDAHPNRQ-ZJKZPDEISA-N |
Pubchem: | 5479543 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AMOTL2 | CCLE | pan-cancer | AAC | -0.23 | 0.005 |
mRNA | KIAA1191 | CCLE | pan-cancer | AAC | -0.21 | 0.0008 |
mRNA | MCOLN2 | CCLE | pan-cancer | AAC | -0.2 | 5e-05 |
mRNA | C2orf81 | CCLE | pan-cancer | AAC | -0.19 | 1e-05 |
mRNA | FADS3 | CCLE | pan-cancer | AAC | -0.19 | 4e-05 |
mRNA | WDR54 | CCLE | pan-cancer | AAC | -0.19 | 3e-05 |
mRNA | SLC39A3 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
mRNA | IFT43 | CCLE | pan-cancer | AAC | -0.18 | 0.0005 |
mRNA | CYP2U1 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
mRNA | CEP19 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |